ArticlePharmaceutical research2015

Improved pharmacokinetic and biodistribution properties of the selective urokinase inhibitor PAI-2 (SerpinB2) by site-specific PEGylation: implications for drug delivery.

Kara Lea Vine et al.PubMed ↗Publisher ↗

No numbers read from the abstract.